{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:59:48Z","timestamp":1790513988218,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clinbiochem.2017.07.011","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T04:32:11Z","timestamp":1500611531000},"page":"1281-1288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Biomarkers of cancer cachexia"],"prefix":"10.1016","volume":"50","author":[{"given":"Audrey","family":"Loumaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9165-0364","authenticated-orcid":false,"given":"Jean-Paul","family":"Thissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.07.011_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.clinbiochem.2017.07.011_bb0015","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.clinbiochem.2017.07.011_bb0025","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","article-title":"Muscle wasting in cancer","volume":"45","author":"Johns","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2017.07.011_bb0030","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.biocel.2013.06.021","article-title":"Muscle wasting: the gut microbiota as a new therapeutic target?","volume":"45","author":"Bindels","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/bjc.1993.4","article-title":"Humoral mediation for cachexia in tumour-bearing rats","volume":"67","author":"Tessitore","year":"1993","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0040","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI116897","article-title":"Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model","volume":"92","author":"Costelli","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0045","article-title":"Differential effects of interleukin-6 and activin A in the development of cancer-associated cachexia","author":"Chen","year":"2016","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.07.011_bb0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1006\/bbrc.1996.0651","article-title":"Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats","volume":"221","author":"Llovera","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.clinbiochem.2017.07.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","article-title":"Tumors secreting human TNF\/cachectin induce cachexia in mice","volume":"50","author":"Oliff","year":"1987","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0065","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00424-008-0574-6","article-title":"Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc (Min\/+) mouse","volume":"457","author":"Baltgalvis","year":"2009","journal-title":"Pflugers Arch."},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0070","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/cncr.11178","article-title":"Elevation of cytokine levels in cachectic patients with prostate carcinoma","volume":"97","author":"Pfitzenmaier","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0075","first-page":"454","article-title":"Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate\u2013preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy","volume":"17","author":"Grim-Stieger","year":"2008","journal-title":"Eur. J. Cancer Care"},{"issue":"11","key":"10.1016\/j.clinbiochem.2017.07.011_bb0080","first-page":"3071","article-title":"Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer","volume":"21","author":"Suh","year":"2013","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.07.011_bb0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0090","first-page":"1091","article-title":"Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival","volume":"21","author":"Moses","year":"2009","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.clinbiochem.2017.07.011_bb0095","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/bjc.1996.294","article-title":"The relationship between weight loss and interleukin 6 in non-small-cell lung cancer","volume":"73","author":"Scott","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.coc.0000221300.72657.e0","article-title":"Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients","volume":"29","author":"Kayacan","year":"2006","journal-title":"Am. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0105","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3892\/ol.2016.5183","article-title":"Growth differentiating factor-15 (GDF-15): a potential biomarker and therapeutic target for cancer-associated weight loss","volume":"12","author":"Lerner","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0110","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","author":"Lerner","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Scheede-Bergdahl","year":"2012","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2016.3","article-title":"Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia","volume":"114","author":"Penafuerte","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.clinbiochem.2017.07.011_bb0125","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-08-0549","article-title":"The biology of activin: recent advances in structure, regulation and function","volume":"202","author":"Xia","year":"2009","journal-title":"J. Endocrinol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0135","first-page":"2125","article-title":"Serum immunoreactive activin a levels in normal subjects and patients with various diseases","volume":"81","author":"Harada","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0140","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Chen","year":"2014","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0145","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1152\/ajpendo.00193.2009","article-title":"Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin","volume":"297","author":"Gilson","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1593\/neo.81582","article-title":"Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma","volume":"11","author":"Seder","year":"2009","journal-title":"Neoplasia"},{"issue":"22","key":"10.1016\/j.clinbiochem.2017.07.011_bb0155","first-page":"4371","article-title":"Activin A as a novel biomarker for colorectal adenocarcinoma in humans","volume":"19","author":"Wu","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0160","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of Activin A and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"10","key":"10.1016\/j.clinbiochem.2017.07.011_bb0170","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/annonc\/mds068","article-title":"Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy","volume":"23","author":"Terpos","year":"2012","journal-title":"Ann. Oncol."},{"issue":"2 Pt B","key":"10.1016\/j.clinbiochem.2017.07.011_bb0175","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.canlet.2014.10.037","article-title":"Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer","volume":"356","author":"Togashi","year":"2015","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.clinbiochem.2017.07.011_bb0180","doi-asserted-by":"crossref","first-page":"13388","DOI":"10.18632\/oncotarget.7796","article-title":"High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma","volume":"7","author":"Hoda","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12209","article-title":"Circulating Activin A predicts survival in cancer patients","author":"Loumaye","year":"2017","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"6628","key":"10.1016\/j.clinbiochem.2017.07.011_bb0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0195","first-page":"C1258","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"7","key":"10.1016\/j.clinbiochem.2017.07.011_bb0200","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/en.2006-1500","article-title":"Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression","volume":"148","author":"Durieux","year":"2007","journal-title":"Endocrinology"},{"issue":"5572","key":"10.1016\/j.clinbiochem.2017.07.011_bb0205","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/micr.20392","article-title":"Time-dependent expression of myostatin RNA transcript and protein in gastrocnemius muscle of mice after sciatic nerve resection","volume":"27","author":"Shao","year":"2007","journal-title":"Microsurgery"},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/rej.2007.0588","article-title":"Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation","volume":"11","author":"Leger","year":"2008","journal-title":"Rejuvenation Res."},{"issue":"7","key":"10.1016\/j.clinbiochem.2017.07.011_bb0220","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Costelli","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2015.12.019","article-title":"Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice","volume":"91","author":"Assi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0230","first-page":"343","article-title":"Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J. Nutr. Health Aging"},{"issue":"25","key":"10.1016\/j.clinbiochem.2017.07.011_bb0235","doi-asserted-by":"crossref","first-page":"14938","DOI":"10.1073\/pnas.95.25.14938","article-title":"Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting","volume":"95","author":"Gonzalez-Cadavid","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0240","doi-asserted-by":"crossref","first-page":"H1973","DOI":"10.1152\/ajpheart.00200.2011","article-title":"Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting","volume":"300","author":"Breitbart","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2008.12.019","article-title":"Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration","volume":"302","author":"Lakshman","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0250","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/gerona\/glr025","article-title":"Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men","volume":"66","author":"Ratkevicius","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0255","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1530\/EJE-12-0512","article-title":"Serum myostatin levels are negatively associated with abdominal aortic calcification in older men: the STRAMBO study","volume":"167","author":"Szulc","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0260","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cmet.2016.05.023","article-title":"Quantification of GDF11 and Myostatin in human aging and cardiovascular disease","volume":"23","author":"Schafer","year":"2016","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.clinbiochem.2017.07.011_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080454","article-title":"Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients","volume":"8","author":"Breitbart","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-213X-9-24","article-title":"Redundancy of myostatin and growth\/differentiation factor 11 function","volume":"9","author":"McPherron","year":"2009","journal-title":"BMC Dev. Biol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0275","doi-asserted-by":"crossref","first-page":"531","DOI":"10.15252\/emmm.201607231","article-title":"Supraphysiological levels of GDF11 induce striated muscle atrophy","volume":"9","author":"Hammers","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08977194.2011.607137","article-title":"The TGF-beta superfamily cytokine, MIC-1\/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism","volume":"29","author":"Breit","year":"2011","journal-title":"Growth Factors"},{"issue":"11","key":"10.1016\/j.clinbiochem.2017.07.011_bb0285","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0290","article-title":"Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo","author":"Patel","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0295","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum","volume":"100","author":"Welsh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.clinbiochem.2017.07.011_bb0300","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.jid.2016.07.016","article-title":"High GDF-15 serum levels independently correlate with poorer overall survival of patients with tumor-free stage III and Unresectable Stage IV melanoma","volume":"136","author":"Weide","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"7516","key":"10.1016\/j.clinbiochem.2017.07.011_bb0305","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"issue":"6039","key":"10.1016\/j.clinbiochem.2017.07.011_bb0310","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.07.011_bb0315","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/jc.2015-3785","article-title":"Serum PTHrP predicts weight loss in cancer patients independent of hypercalcemia, inflammation, and tumor burden","volume":"101","author":"Hong","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-012-0086-2","article-title":"Serological muscle loss biomarkers: an overview of current concepts and future possibilities","volume":"4","author":"Nedergaard","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.clinbiochem.2017.07.011_bb0325","first-page":"2291","article-title":"Ntau-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview","volume":"37","author":"Young","year":"1978","journal-title":"Fed. Proc."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13539-013-0117-7","article-title":"Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss","volume":"5","author":"Sheffield-Moore","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.07.011_bb0335","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj2140607","article-title":"3-Methylhistidine turnover in the whole body, and the contribution of skeletal muscle and intestine to urinary 3-methylhistidine excretion in the adult rat","volume":"214","author":"Millward","year":"1983","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0838.2007.00766.x","article-title":"Myofibrillar proteolysis in response to voluntary or electrically stimulated muscle contractions in humans","volume":"19","author":"Hansen","year":"2009","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0345","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exger.2014.07.016","article-title":"Measurement of a MMP-2 degraded titin fragment in serum reflects changes in muscle turnover induced by atrophy","volume":"58","author":"Sun","year":"2014","journal-title":"Exp. Gerontol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2017.07.011_bb0350","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2014.03.012","article-title":"Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy","volume":"24","author":"Rouillon","year":"2014","journal-title":"Neuromuscul. Disord."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0355","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcsm.12027","article-title":"Collagen fragment biomarkers as serological biomarkers of lean body mass - a biomarker pilot study from the DAHANCA25B cohort and matched controls","volume":"6","author":"Nedergaard","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.07.011_bb0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13539-013-0120-z","article-title":"Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults","volume":"5","author":"Fragala","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"12","key":"10.1016\/j.clinbiochem.2017.07.011_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144525","article-title":"Collagen type III and VI turnover in response to long-term immobilization","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123566","article-title":"Circulating carnosine dipeptidase 1 associates with weight loss and poor prognosis in gastrointestinal cancer","volume":"10","author":"Arner","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0375","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI18330","article-title":"Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions","volume":"113","author":"Du","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.clinbiochem.2017.07.011_bb0380","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1681\/ASN.2006020131","article-title":"Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions","volume":"17","author":"Workeneh","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jcsm.12005","article-title":"Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients","volume":"6","author":"Stephens","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.07.011_bb0390","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccr.2005.10.004","article-title":"Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia","volume":"8","author":"Acharyya","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0395","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10409238.2013.857291","article-title":"Signaling pathways controlling skeletal muscle mass","volume":"49","author":"Egerman","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm122","article-title":"Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia","volume":"2","author":"Stephens","year":"2010","journal-title":"Genome Med."},{"issue":"10","key":"10.1016\/j.clinbiochem.2017.07.011_bb0405","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/1078-0432.CCR-11-2133","article-title":"Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies","volume":"18","author":"Gallagher","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"Pt 2","key":"10.1016\/j.clinbiochem.2017.07.011_bb0410","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1113\/jphysiol.2007.138529","article-title":"Effect of endurance exercise training on Ca2+ calmodulin-dependent protein kinase II expression and signalling in skeletal muscle of humans","volume":"583","author":"Rose","year":"2007","journal-title":"J. Physiol."},{"issue":"Pt 7","key":"10.1016\/j.clinbiochem.2017.07.011_bb0415","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1113\/jphysiol.2008.167528","article-title":"A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions","volume":"587","author":"Rose","year":"2009","journal-title":"J. Physiol."},{"issue":"6535","key":"10.1016\/j.clinbiochem.2017.07.011_bb0420","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/376070a0","article-title":"Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation","volume":"376","author":"Sato","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7007-3-19","article-title":"Modulation of extracellular matrix genes reflects the magnitude of physiological adaptation to aerobic exercise training in humans","volume":"3","author":"Timmons","year":"2005","journal-title":"BMC Biol."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0430","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fphys.2016.00472","article-title":"Cancer and chemotherapy contribute to muscle loss by activating common signaling pathways","volume":"7","author":"Barreto","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12188","article-title":"Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: A pilot study","author":"Ebhardt","year":"2017","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0440","first-page":"239","article-title":"Mega roles of microRNAs in regulation of skeletal muscle health and disease","volume":"5","author":"Sharma","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0445","doi-asserted-by":"crossref","first-page":"367561","DOI":"10.1155\/2015\/367561","article-title":"Cancer cachexia and MicroRNAs","volume":"2015","author":"Camargo","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0450","doi-asserted-by":"crossref","DOI":"10.1152\/physiolgenomics.00006.2017","article-title":"Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size","author":"Lee","year":"2017","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12168","article-title":"Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia","author":"Narasimhan","year":"2017","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"16","key":"10.1016\/j.clinbiochem.2017.07.011_bb0460","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-13-2817","article-title":"Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle","volume":"74","author":"Chen","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0465","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2013.12.003","article-title":"Myostatin signaling regulates Akt activity via the regulation of miR-486 expression","volume":"47","author":"Hitachi","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"32","key":"10.1016\/j.clinbiochem.2017.07.011_bb0470","doi-asserted-by":"crossref","first-page":"21909","DOI":"10.1074\/jbc.M114.561845","article-title":"Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions","volume":"289","author":"Soares","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.clinbiochem.2017.07.011_bb0475","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1073\/pnas.1402714111","article-title":"Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7","volume":"111","author":"He","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.clinbiochem.2017.07.011_bb0480","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1158\/0008-5472.CAN-06-4585","article-title":"Mechanism of increased lipolysis in cancer cachexia","volume":"67","author":"Agustsson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0485","doi-asserted-by":"crossref","first-page":"820934","DOI":"10.1155\/2015\/820934","article-title":"Potential biomarkers of fat loss as a feature of cancer cachexia","volume":"2015","author":"Ebadi","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clinbiochem.2017.07.011_bb0490","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1186\/1471-2407-14-828","article-title":"Emerging markers of cachexia predict survival in cancer patients","volume":"14","author":"Mondello","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.07.011_bb0495","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cyto.2010.05.006","article-title":"Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tract","volume":"51","author":"Diakowska","year":"2010","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0500","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0148607105029004229","article-title":"Hypoleptinemia in gastric cancer patients: relation to body fat mass, insulin, and growth hormone","volume":"29","author":"Huang","year":"2005","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"issue":"9","key":"10.1016\/j.clinbiochem.2017.07.011_bb0505","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.nut.2011.11.026","article-title":"Adipose tissue volume is decreased in recently diagnosed cancer patients with cachexia","volume":"28","author":"Agustsson","year":"2012","journal-title":"Nutrition"},{"issue":"10","key":"10.1016\/j.clinbiochem.2017.07.011_bb0510","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/sj.bjc.6605665","article-title":"Adipose tissue pathways involved in weight loss of cancer cachexia","volume":"102","author":"Dahlman","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0515","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2796.2011.02441.x","article-title":"Adipose zinc-alpha2-glycoprotein is a catabolic marker in cancer and noncancerous states","volume":"271","author":"Ryden","year":"2012","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.07.011_bb0520","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjc.6606083","article-title":"Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients","volume":"104","author":"Mracek","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.07.011_bb0525","doi-asserted-by":"crossref","first-page":"E267","DOI":"10.1152\/ajpendo.00249.2013","article-title":"MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia","volume":"306","author":"Kulyte","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.07.011_bb0530","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12041-014-0405-9","article-title":"Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies","volume":"93","author":"Johns","year":"2014","journal-title":"J. Genet."},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.07.011_bb0535","first-page":"229","article-title":"Biomarkers for cancer cachexia: is there also a genetic component to cachexia?","volume":"16","author":"Tan","year":"2008","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.07.011_bb0540","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SPC.0b013e32833e4a5d","article-title":"Cytokine gene polymorphisms and susceptibility to cachexia","volume":"4","author":"Tan","year":"2010","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.07.011_bb0545","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/emmm.201200231","article-title":"P-selectin genotype is associated with the development of cancer cachexia","volume":"4","author":"Tan","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"9","key":"10.1016\/j.clinbiochem.2017.07.011_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108057","article-title":"AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients","volume":"9","author":"Avan","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.07.011_bb0555","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jcsm.12138","article-title":"New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss","volume":"8","author":"Johns","year":"2017","journal-title":"J. Cachex. Sarcopenia Muscle"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912017304277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912017304277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:54:21Z","timestamp":1757865261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912017304277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":111,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0009912017304277"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.07.011","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}